Modified hemoglobin blood substitutes: present status and future perspectives.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biotechnology Annual Review

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/S1387-2656(08)70068-1PMID 9890139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo evaluation of a pyridoxylated-hemoglobin-polyoxyethylene conjugate.

  2009cited by this paper
• Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury.

  1997cited by this paper
• Blood Substitutes: Principles, Methods, Products and Clinical Trials

  1997cited by this paper
• Ferrrous hemoglobin scavenging of endothelium derived nitric oxide is a principal mechanism for hemoglobin mediated vasoactivities in isolated rat thoracic aorta.

  1997cited by this paper
• Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells.

  1997cited by this paper
• Reduction of hydroxyl radical generation in a rat hindlimb model of ischemia-reperfusion injury using crosslinked hemoglobin-superoxide dismutase-catalase.

  1997cited by this paper
• Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient.

  1997cited by this paper
• Protein engineering strategies for designing more stable hemoglobin-based blood substitutes.

  1997cited by this paper
• Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes.

  1997cited by this paper
• Resuscitation with diaspirin crosslinked hemoglobin increases cerebral and renal blood perfusion in hemorrhaged rats.

  1997cited by this paper
• Construction of artificial methemoglobin reduction systems in Hb vesicles.

  1997cited by this paper
• Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin.

  1996cited by this paper
• Blood substitutes in development

  1996cited by this paper
• S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control

  1996cited by this paper
• Microvascular and tissue oxygen distribution.

  1996cited by this paper
• Section Review: Cardiovascular & Renal: Blood substitutes in development

  1996cited by this paper
• Clinical Development of Human Polymerized Hemoglobin as a Blood Substitute

  1996cited by this paper
• Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.

  1996cited by this paper
• Hemoglobin-Endotoxin Interactions

  1996cited by this paper
• Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid.

  1996cited by this paper
• Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies.

  1996cited by this paper
• Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans.

  1996cited by this paper
• Treatment of massive hemorrhage with liposome encapsulated human hemoglobin (NRC) and hydroxyethyl starch (HES) in beagles.

  1996cited by this paper
• Physical Properties of Hemoglobin Vesicles as Red Cell Substitutes

  1996cited by this paper
• The cytotoxic activities of human hemoglobin and diaspirin crosslinked hemoglobin.

  1996cited by this paper
• Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): Effects on hematopoiesis and serum IL-6 levels.

  1996cited by this paper
• Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

  1996cited by this paper
• Diaspirin crosslinked hemoglobin (DCLHb): more effective than lactated Ringer's solution in restoring central venous oxygen saturation after hemorrhagic shock in rats.

  1996cited by this paper
• The physiological and histopathological response of dogs to exchange transfusion with polyethylene glycol-modified bovine hemoglobin (PEG-Hb).

  1996cited by this paper
• Evaluation of the immunogenicity of polymerized hemoglobin solutions in a rabbit model.

  1995cited by this paper
• Effect and safety of liposome-encapsulated hemoglobin neo red cells (NRCs) as a perfusate for total cardiopulmonary bypass.

  1995cited by this paper
• Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects.

  1995cited by this paper
• Role of nitric oxide scavenging in peripheral vasoconstrictor response to beta beta cross-linked hemoglobin.

  1995cited by this paper
• Characterization of neo red cells (NRCs), their function and safety in vivo tests.

  1995cited by this paper
• Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro.

  1995cited by this paper
• Resuscitation with Diaspirin Crosslinked Hemoglobin in a pig model of hemorrhagic shock.

  1995cited by this paper
• A comparative study of the accurate measurement of endotoxin in liposome-encapsulated hemoglobin.

  1995cited by this paper
• Artificial cells with emphasis on bioencapsulation in biotechnology.

  1995cited by this paper
• The development of hemoglobin solutions as red cell substitutes: hemoglobin solutions.

  1995cited by this paper
• Role of Nitric Oxide Scavenging in Peripheral Vasoconstrictor Response to ββ Cross-Linked Hemoglobin

  1995cited by this paper
• Blood substitutes : physiological basis of efficacy

  1995cited by this paper
• Encapsulation of Hemoglobin in Liposomes

  1995cited by this paper
• Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.

  1994cited by this paper
• Cross-linking hemoglobin by design: lessons from using molecular clamps.

  1994cited by this paper
• Assessment of blood substitutes: II. In-vitro complement activation of human plasma and blood for safety studies in research, development, industrial production and preclinical analysis.

  1994cited by this paper
• Encapsulated hemoglobin: current issues and future goals.

  1994cited by this paper
• Stabilized hemoglobin vesicles.

  1994cited by this paper
• The efficacy of diaspirin crosslinked hemoglobin solution resuscitation in a model of uncontrolled hemorrhage.

  1994cited by this paper
• Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin.

  1994cited by this paper
• Assessment of blood substitutes: I. Efficacy studies in anesthetized and conscious rats with loss of 1/3, 1/2 and 2/3 blood volume.

  1994cited by this paper
• Points to consider on efficacy evaluation of hemoglobin‐ and perfluorocarbon‐based oxygen carriers. Center for Biologics Evaluation and Research

  1994cited by this paper
• Artificial Cell Including Blood Substitute and Biomicroencapsulation: from Ideas to Applications

  1994cited by this paper
• PEG-hemoglobin: an efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models.

  1994cited by this paper
• Use of finger-prick human blood samples as a more convenient way for in-vitro screening of modified hemoglobin blood substitutes for complement activation: a preliminary report.

  1993cited by this paper
• Safety studies of modified hemoglobin as an oxygen-carrying blood substitute.

  1993cited by this paper
• Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free radicals and prevents methemoglobin formation and iron release.

  1993cited by this paper
• Detection of membrane fragments in hemoglobin solutions.

  1992cited by this paper
• Modified hemoglobin solution as possible perfusate relevant to organ transplantation.

  1992cited by this paper
• Clearance of differentially labelled infused hemoglobin and polymerized hemoglobin from dog plasma and accumulation in urine and selected tissues.

  1992cited by this paper
• Synthesis and characterization of artificial red cell (ARC).

  1992cited by this paper
• Effects of liposome encapsulated hemoglobin on the reticuloendothelial system.

  1992cited by this paper
• Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe hemorrhage in the rat.

  1992cited by this paper
• Preparation, properties and biological function of liposome encapsulated hemoglobin.

  1992cited by this paper
• Relationship between chemical properties and biological properties of pyridoxalated hemoglobin-polyoxyethylene.

  1992cited by this paper
• Studies on the quality control of stroma-free hemoglobin.

  1992cited by this paper
• Dehydration and shock: an animal model of hemorrhage and resuscitation of battlefield injury.

  1992cited by this paper
• Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin.

  1992cited by this paper
• Evaluating new red cell substitutes: a critical analysis of toxicity models.

  1992cited by this paper
• Effects of intravenous infusions of diaspirin cross-linked hemoglobin (DCLHb) on sheep.

  1992cited by this paper
• Biodistribution studies of liposome encapsulated hemoglobin (LEH) studied with a newly developed 99m-technetium liposome label.

  1992cited by this paper
• A human recombinant haemoglobin designed for use as a blood substitute

  1992cited by this paper
• Immunogenicity of diaspirin cross-linked human hemoglobin solutions.

  1992cited by this paper
• Points to consider in the safety evaluation of hemoglobin‐based oxygen carriers

  1991cited by this paper
• Encyclopedia of human biology

  1991cited by this paper
• A screening test for modified hemoglobin blood substitutes before clinical use: based on C3a complement activation in human plasma.

  1990cited by this paper
• Expression of fully functional tetrameric human hemoglobin in Escherichia coli.

  1990cited by this paper
• In Vivo Effects of Stroma-Free Hemoglobin and Polyhemoglobin on Coagulation Factors in Rats

  1990cited by this paper
• Effects of homologous and heterologous stroma-free hemoglobin and polyhemoglobin on complement activation, leucocytes and platelets.

  1990cited by this paper
• Editorial: Modified Hemoglobin: Endotoxin and Safety Studies

  1990cited by this paper
• Effects of pyridoxalated polyhemoglobin and stroma-free hemoglobin on ADP-induced platelet aggregation.

  1989cited by this paper
• Rightshifted dextran-hemoglobin as blood substitute.

  1988cited by this paper
• Effects of stroma-free hemoglobin solutions on isolated perfused rabbit hearts and isolated perfused rat kidneys.

  1988cited by this paper
• Liposome/heme as a totally synthetic oxygen carrier.

  1988cited by this paper
• Mechanisms of toxicity of hemoglobin solutions.

  1988cited by this paper
• (Pyridoxalated Hemoglobin)-(Polyoxyethylene) Conjugate Solution as Blood Substitute for Normothermic Whole Body Rinse-Out

  1988cited by this paper
• Immunological and systemic effects of transfusions in rats using pyridoxylated hemoglobin and polyhemoglobin from homologous and heterogeneous sources.

  1988cited by this paper
• Hemoglobin: a lifesaver and an oxidant. How to tip the balance.

  1988cited by this paper
• Pyridoxylated-polyhemoglobin solution: a low viscosity oxygen-delivering blood replacement fluid with normal oncotic pressure and long-term storage feasibility.

  1988cited by this paper
• Liposome-encapsulated hemoglobin: oxygen binding properties and respiratory function.

  1988cited by this paper
• Preparation of virus-free pyridoxylated hemoglobin from the blood of HBV or HTLV-I healthy carriers.

  1988cited by this paper
• Effects of Stroma-Free Hemoglobin and Polyhemoglobin on Complement Activation, Blood Cells and Coagulation Factors in Rats

  1988cited by this paper
• Metabolism, Distribution, and Excretion of HbXL: A Nondissociating Interdimerically Crosslinked Hemoglobin with Exceptional Oxygen Offloading Capability

  1988cited by this paper
• Conjugated Hemoglobin: Rightshifted Dextran-Hemoglobin as Blood Substitute

  1988cited by this paper
• Effects of Partial and Total Isovolemic Exchange Transfusion in Fully Conscious Rats Using Pyridoxylated Polyhemoglobin Solution as a Colloidal Oxygen‐Delivering Blood Replacement Fluid 1

  1987cited by this paper
• Pyridoxalated heterogenous and homologous polyhemoglobin and hemoglobin: systemic effects of replacement transfusion in rats previously received immunizing doses.

  1987cited by this paper
• Serum Antibody Titers in Rats Receiving Repeated Small Subcutaneous Injections of Hemoglobin or Polyhemoglobin: A Preliminary Report

  1986cited by this paper
• [15] Artificial cells containing multienzyme systems

  1985cited by this paper
• Effect of pyridoxalated stabilized stroma-free hemoglobin solution on the clearance of intravascular lipid by the reticuloendothelial system.

  1985cited by this paper
• Artificial cells containing multienzyme systems.

  1985cited by this paper
• Pyridoxylated polyhemoglobin as a red cell substitute for resuscitation of lethal hemorrhagic shock in conscious rats.

  1985cited by this paper

• Steps Toward Recapitulating Endothelium: A Perspective on the Next Generation of Hemocompatible Coatings.

  2024cites this paper
• Engineering Synthetic Erythrocytes as Next‐Generation Blood Substitutes

  2024cites this paper
• Wiederherstellung von Sauerstoffverfügbarkeit und hepatozellulärem Energiestoffwechsel durch Perfluorocarbone : eine tierexperimentelle Studie im hämorrhagischen Schock

  2013cites this paper
• Low modulus biomimetic microgel particles with high loading of hemoglobin.

  2012cites this paper
• Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemia

  2008cites this paper
• Application of zero-length cross-linking to form lysozyme, horseradish peroxidase and lysozyme-peroxidase dimers: Activity and stability.

  2007cites this paper
• Einfluss von moderater Hämodilution mit Dextran-Konjugiertem Hämoglobin auf die Mikrozirkulation

  2007cites this paper
• Blood substitutes as pharmacotherapies in clinical practice

  2007cites this paper
• The effects of perioperative blood transfusion on morbidity and mortality after esophagectomy.

  2006cites this paper
• Oxygen Carriers in Cardiac Surgery

  2005cites this paper
• Experimental studies on artificial blood usage for hemodilution during cardiopulmonary bypass.

  2005cites this paper
• Blood substitutes and oxygen therapeutics: an overview and current status.

  2002cites this paper
• Covalent cross‐linking of proteins without chemical reagents

  2002cites this paper
• Preservation of myocardial energy status by bovine hemoglobin solutions during ischemia.

  2002cites this paper
• SUPEROXIDE GENERATION FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY LIPOSOME-ENCAPSULATED HEMOGLOBIN

  2001cites this paper
• Mechanistic studies of the oxidation of pyridoxalated hemoglobin polyoxyethylene conjugate by nitrogen monoxide.

  1999cites this paper